Comparative study of garlic powder and gemfibrozil in patients of ischemic heart disease and diabetes mellitus

ABSTRACT

In this study we observed the effects of garlic [Allium sativum] powder on lipid profile in hyperlipidaemic patients [fasting serum cholesterol 280 mg / 100 ml or more and / or triglyceride 180 mg / 100ml or more] suffering from ischemic heart disease [IHD] and diabetes mellitus [DM] and compared its effects with those of the standard lipid regulating drug gemfibrozil [Lopid]. Nine patients suffering from IHD and DM were put on garlic powder [6 gram / day] for a period of four weeks, six patients were put on gemfibrozil [1200 mg/day] for a period of four weeks. After completion of the treatment the lipid profile was again examined. The parameters studied were serum total lipids, cholesterol, triglyceride, low density lipoprotein- cholesterol [LDL-C] and high density lipoprotein-cholesterol [HDL-C]. The reduction in the garlic treated group of patients of serum total lipids, cholesterol, triglyceride and LDL-C was more marked as compared the gemfibrozil treated patients. Garlic increased the mean serum HDL-C levels very significantly. All these changes produced by garlic powder are beneficial in patients of IHD and DM which are at high risk. Serum total lipids, cholesterol, triglycerides and LDL-C directly or indirectly enhance the process of atherosclerosis, while HDL-C slows this process by taking away cholesterol from arteries towards the liver for its metabolism and excretion. So garlic is very useful dietary component for slowing the process of atherosclerosis and its associated complications in high risk patients if used regularly for a long time